Members
Saint Gobain Opens New Production Facility In Dublin
Saint Gobain Life Sciences have unveiled their new production facility in Citywest, Dublin.
The new facility will enable the company to increase production and further expand its presence in the manufacture and supply from Ireland to the life sciences and biopharmaceutical sectors both nationally and internationally, Saint Gobain say.
The company expects its staff to grow from 80 to between 110 and 120 people over the next three years if its current growth trajectory continues.
The new facility will enable Saint-Gobain Life to manufacture high-specification over-moulded components and assemblies and marks a significant advance in its ability to meet the ever-accelerating demands of the Biotech industry.
The products that are made have helped with the manufacture of drugs such as Covid-19 and HIV Therapies, Cancer, and Diabetes Drugs, Orphan Drugs for Rare Diseases, Vaccines as well as groundbreaking Cell and Gene therapies.
Saint Gobain Life Sciences have unveiled their new production facility in Citywest, Dublin.
The new facility will enable the company to increase production and further expand its presence in the manufacture and supply from Ireland to the life sciences and biopharmaceutical sectors both nationally and internationally, Saint Gobain say.
The company expects its staff to grow from 80 to between 110 and 120 people over the next three years if its current growth trajectory continues.
The new facility will enable Saint-Gobain Life to manufacture high-specification over-moulded components and assemblies and marks a significant advance in its ability to meet the ever-accelerating demands of the Biotech industry.
The products that are made have helped with the manufacture of drugs such as Covid-19 and HIV Therapies, Cancer, and Diabetes Drugs, Orphan Drugs for Rare Diseases, Vaccines as well as groundbreaking Cell and Gene therapies.
They established their presence in Ireland through acquisition in 2018 and have experienced rapid growth in both turnover and its number of employees, growing from just 19 employees in 2018.
“This new production facility will enable us to expand our production capabilities for the supply of essential materials to the life sciences sector,” said Sung Yu, CEO of Saint-Gobain Life Sciences.
“Ireland is a global centre for the life sciences sector, and our company is a vital part of the supply chain for this key industry.”
